32.69

0.27% -0.10

Harmony Biosciences Holdings Inc (HRMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRMY Giù? Forum Previsione

Precedente Chiudi:

$32.79

Aprire:

$32.85

Volume 24 ore:

31,902

Relative Volume:

0.05

Capitalizzazione di mercato:

$1.87B

Reddito:

$656.11M

Utile/perdita netta:

$114.99M

Rapporto P/E:

13.29

EPS:

2.46

Flusso di cassa netto:

$212.78M

1 W Prestazione:

-0.91%

1M Prestazione:

-6.44%

6M Prestazione:

+10.29%

1 anno Prestazione:

+19.04%

Intervallo 1D:

$32.33

$33.01

Intervallo di 1 settimana:

$32.33

$33.66

Portata 52W:

$27.97

$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Nome

Harmony Biosciences Holdings Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

(484) 539-9800

Indirizzo

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Dipendente

246

Cinguettio

Prossima data di guadagno

2024-10-29

Ultimi documenti SEC

HRMY's Discussions on Twitter

Confronta HRMY con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRMY	32.69	1.87B	656.11M	114.99M	212.78M	2.46
VRTX	446.08	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	740.77	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.60	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.12	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.86	24.49B	3.30B	-501.07M	1.03B	11.54

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-21	Iniziato	Citigroup	Buy
2024-01-02	Downgrade	BofA Securities	Neutral → Underperform
2023-09-25	Downgrade	Goldman	Neutral → Sell
2023-09-07	Iniziato	Berenberg	Buy
2023-04-20	Iniziato	BofA Securities	Neutral
2022-10-14	Aggiornamento	Janney	Neutral → Buy
2022-10-14	Aggiornamento	Jefferies	Hold → Buy
2022-08-03	Downgrade	Jefferies	Buy → Hold
2022-07-13	Downgrade	Goldman	Buy → Neutral
2022-07-07	Iniziato	Mizuho	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-04	Iniziato	Raymond James	Outperform
2021-09-23	Iniziato	Needham	Buy
2021-03-29	Aggiornamento	Goldman	Neutral → Buy
2020-09-14	Iniziato	Goldman	Neutral
2020-09-14	Iniziato	Jefferies	Buy
2020-09-14	Iniziato	Piper Sandler	Overweight

Mostra tutto

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

09:17 AM

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - BioSpace

09:17 AM

08:05 AM

Harmony Biosciences to Present at Citi and Piper Sandler Healthcare Conferences | HRMY Stock News - StockTitan

08:05 AM

05:24 AM

Harmony Biosciences Reports Record Revenue and Plans Expansion in CNS Treatments - MSN

05:24 AM

Nov 20, 2024

HRMY (Harmony Biosciences Holdings) GF Value Rank : 4 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Principal Financial Group Inc. - MarketBeat

Nov 20, 2024

Quest Partners LLC Acquires 20,689 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Nov 20, 2024

Nov 18, 2024

First Week of July 2025 Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq

Nov 18, 2024

Nov 17, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Significant Drop in Short Interest - MarketBeat

Nov 17, 2024

Nov 12, 2024

14,396 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by CWA Asset Management Group LLC - MarketBeat

Nov 12, 2024

Nov 11, 2024

Harmony Biosciences’ Common Stock Offering - Global Legal Chronicle

Nov 11, 2024

Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points (NASDAQ:HRMY) - Seeking Alpha

Nov 11, 2024

Nov 08, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 08, 2024

Nov 06, 2024

Harmony Biosciences director Antonio Gracias sells $139m in stock - Investing.com India

Nov 06, 2024

Nov 05, 2024

Marshman Fund Trust II sells $139.39 million in Harmony Biosciences stock - Investing.com

Nov 05, 2024

Harmony Biosciences director Antonio Gracias sells $139m in stock By Investing.com - Investing.com UK

Nov 05, 2024

AlphaCentric Advisors LLC Has $3.88 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Nov 05, 2024

There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings - Yahoo Canada Finance

Nov 05, 2024

Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 01, 2024

Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance

Nov 01, 2024

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance

Nov 01, 2024

Oct 31, 2024

Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat - MSN

Oct 31, 2024

Harmony Biosciences Holdings Prices of Public Offering of Common Stock - citybiz

Oct 31, 2024

Harmony Biosciences chief commercial officer sells $870,018 in stock - Investing.com India

Oct 31, 2024

Harmony Biosciences chief commercial officer sells $870,018 in stock By Investing.com - Investing.com Canada

Oct 31, 2024

Latham Advises Harmony Biosciences Holdings, Inc. in Public Offering of Common Stock by Selling Shareholders - Latham & Watkins LLP

Oct 31, 2024

HRMY Makes Notable Cross Below Critical Moving Average - Nasdaq

Oct 31, 2024

Harmony Biosciences (NASDAQ:HRMY) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat

Oct 31, 2024

Cantor Fitzgerald Issues Positive Estimate for HRMY Earnings - MarketBeat

Oct 31, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024

Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St

Oct 31, 2024

Goldman Sachs maintains sell rating on HRMY stock with $28 target - Investing.com Canada

Oct 31, 2024

Oct 30, 2024